Puretech Health Plc Stock Market Value

PTCHF Stock  USD 1.76  0.06  3.53%   
PureTech Health's market value is the price at which a share of PureTech Health trades on a public exchange. It measures the collective expectations of PureTech Health plc investors about its performance. PureTech Health is trading at 1.76 as of the 13th of January 2026. This is a 3.53 percent increase since the beginning of the trading day. The stock's lowest day price was 1.76.
With this module, you can estimate the performance of a buy and hold strategy of PureTech Health plc and determine expected loss or profit from investing in PureTech Health over a given investment horizon. Check out PureTech Health Correlation, PureTech Health Volatility and PureTech Health Alpha and Beta module to complement your research on PureTech Health.
Symbol

Please note, there is a significant difference between PureTech Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if PureTech Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PureTech Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

PureTech Health 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to PureTech Health's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of PureTech Health.
0.00
11/14/2025
No Change 0.00  0.0 
In 2 months and 1 day
01/13/2026
0.00
If you would invest  0.00  in PureTech Health on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding PureTech Health plc or generate 0.0% return on investment in PureTech Health over 60 days. PureTech Health is related to or competes with Avacta Group, Healios KK, Clinuvel Pharmaceuticals, BioInvent International, Northwest Biotherapeutics, Clinuvel Pharmaceuticals, and MedinCell. PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inf... More

PureTech Health Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure PureTech Health's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess PureTech Health plc upside and downside potential and time the market with a certain degree of confidence.

PureTech Health Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for PureTech Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as PureTech Health's standard deviation. In reality, there are many statistical measures that can use PureTech Health historical prices to predict the future PureTech Health's volatility.
Hype
Prediction
LowEstimatedHigh
0.361.763.16
Details
Intrinsic
Valuation
LowRealHigh
0.241.643.04
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as PureTech Health. Your research has to be compared to or analyzed against PureTech Health's peers to derive any actionable benefits. When done correctly, PureTech Health's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in PureTech Health plc.

PureTech Health plc Backtested Returns

At this point, PureTech Health is relatively risky. PureTech Health plc maintains Sharpe Ratio (i.e., Efficiency) of 0.0615, which implies the firm had a 0.0615 % return per unit of risk over the last 3 months. We have found twenty-one technical indicators for PureTech Health plc, which you can use to evaluate the volatility of the company. Please check PureTech Health's Coefficient Of Variation of (1,923), risk adjusted performance of (0.03), and Variance of 3.53 to confirm if the risk estimate we provide is consistent with the expected return of 0.0861%. PureTech Health has a performance score of 4 on a scale of 0 to 100. The company holds a Beta of -0.15, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning PureTech Health are expected to decrease at a much lower rate. During the bear market, PureTech Health is likely to outperform the market. PureTech Health plc right now holds a risk of 1.4%. Please check PureTech Health plc skewness, as well as the relationship between the rate of daily change and price action indicator , to decide if PureTech Health plc will be following its historical price patterns.

Auto-correlation

    
  0.00  

No correlation between past and present

PureTech Health plc has no correlation between past and present. Overlapping area represents the amount of predictability between PureTech Health time series from 14th of November 2025 to 14th of December 2025 and 14th of December 2025 to 13th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of PureTech Health plc price movement. The serial correlation of 0.0 indicates that just 0.0% of current PureTech Health price fluctuation can be explain by its past prices.
Correlation Coefficient0.0
Spearman Rank Test0.81
Residual Average0.0
Price Variance0.0

PureTech Health plc lagged returns against current returns

Autocorrelation, which is PureTech Health pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting PureTech Health's pink sheet expected returns. We can calculate the autocorrelation of PureTech Health returns to help us make a trade decision. For example, suppose you find that PureTech Health has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

PureTech Health regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If PureTech Health pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if PureTech Health pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in PureTech Health pink sheet over time.
   Current vs Lagged Prices   
       Timeline  

PureTech Health Lagged Returns

When evaluating PureTech Health's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of PureTech Health pink sheet have on its future price. PureTech Health autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, PureTech Health autocorrelation shows the relationship between PureTech Health pink sheet current value and its past values and can show if there is a momentum factor associated with investing in PureTech Health plc.
   Regressed Prices   
       Timeline  

Currently Active Assets on Macroaxis

Additional Information and Resources on Investing in PureTech Pink Sheet

When determining whether PureTech Health plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of PureTech Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Puretech Health Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Puretech Health Plc Stock:
Check out PureTech Health Correlation, PureTech Health Volatility and PureTech Health Alpha and Beta module to complement your research on PureTech Health.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
PureTech Health technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of PureTech Health technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of PureTech Health trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...